Integramed America, Inc. (INMD) Tops Q4 EPS by 3c, Sales Top Consensus
Tweet
Share
E-mailGet Alerts INMD Hot Sheet
Price: $14.81 -0.67%
Revenue Growth %: -1.7%
Financial Fact:
Total costs of services and sales: 65.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -1.7%
Financial Fact:
Total costs of services and sales: 65.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Integramed America, Inc. (NASDAQ: INMD) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $70.88 million versus the consensus estimate of $69.58 million.
For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.
For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Chime to acquire Stride Bank for $590M in cash
- ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
